Brief Title
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Official Title
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations
Brief Summary
1. To determine the prognostic implication of plasma Epstein-Bar Virus (EBV) DNA concentrations, as measured by quantitative polymerase chain reaction (PCR) in patients with nasopharyngeal carcinoma (NPC). 2. To relate pretreatment plasma EBV DNA concentration to WHO classification of these tumors both in endemic and non-endemic areas. 3. To determine whether pretreatment plasma EBV DNA can serve as a prognostic factor for both endemic and non-endemic patient populations.
Study Type
Observational
Primary Outcome
Plasma Epstein-Bar Virus (EBV) DNA concentrations
Condition
Mouth Cancer
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
49
Start Date
November 2001
Completion Date
June 2013
Primary Completion Date
June 2013
Eligibility Criteria
Inclusion Criteria: - Having a new diagnosis of Nasopharyngeal carcinoma. - Being treated with either radiotherapy or chemoradiotherapy for this condition. Exclusion Criteria: - Age <18 since NPC is a very rare condition in this age group and may have a different biological behavior - Patients who are unable to provide informed consents for themselves.
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Quynh-Thu Le, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT00186433
Organization ID
ENT0006
Secondary IDs
ENT0006
Responsible Party
Principal Investigator
Study Sponsor
Stanford University
Study Sponsor
Quynh-Thu Le, Principal Investigator, Stanford University
Verification Date
May 2015